Monthly Archive: January 2014

Jan 31

Dr KK Aggarwal receives Harpal S Buttar Oration Award from Nobel Laureate Dr Ferid Murad

Padma Shri & Dr. B C Roy National Awardee, Dr. K K Aggarwal, President Heart Care Foundation of India is awarded with Harpal S Buttar Oration Award by the 6th International conference of International Academy for Cardiovascular Sciences. The award consists of a memento and a cash prize of Rs. 10000. The Oration was given …

Continue reading »

Jan 30

Vitamin D

In a discussion organized by Zee Media and moderated by Padma Shri & Dr. B C Roy National Awardee, Dr. K K Aggarwal, President, Heart Care Foundation of India, Dr. Ambrish Mithal from Medanta, Dr. Rajesh Malhotra and Dr. P C Khadgawat from AIIMS in a joint statement said that the sunlight is the main …

Continue reading »

Jan 29

Updated draft guidelines from the U.S. Preventive Services Task Force (USPSTF)

Updated draft guidelines from the U.S. Preventive Services Task Force (USPSTF) have reiterated that routine, one–time screening for abdominal aortic aneurysm (AAA) with an ultrasound should be confined to men ages 65 to 75 who have ever smoked. For men in that age group who have never smoked, however, clinicians should offer selective screening on …

Continue reading »

Jan 28

Over 1000 children trained in cardiac first aid

Padma Shri & Dr. B C Roy National Awardee, Dr. KK Aggarwal, President, Heart Care Foundation of India trained over 1000 school children at Guru Harkrishan Public School, Hargovind Enclave in cardiac first aid including how to revive a dead person after sudden cardiac death. Speaking to the children, Dr. Aggarwal said that all school …

Continue reading »

Jan 28

Treating statin–intolerant patients with evolocumab (Amgen, Thousand Oaks, CA)

Treating statin–intolerant patients with evolocumab (Amgen, Thousand Oaks, CA) significantly lowers LDL–cholesterol levels, according to the top–line results of the GAUSS–2 study. Evolocumab is an investigational human monoclonal antibody for proprotein convertase subtilisin–kexin type 9 (PCSK9). The study included 307 patients who were unable to tolerate at least two different statins because of muscle–related side …

Continue reading »

Jan 27

which were low to begin with due to the enrollment criteria, remained low with progesterone therapy.

A randomized, placebo–controlled trial in healthy women in early menopause who had hot flashes suggests that three–month therapy with oral micronized progesterone alone (without estradiol) poses little or no short–term cardiovascular risk. Dr Jerilynn C Prior (Centre for Menstrual Cycle and Ovulation Research, University of British Columbia, Vancouver) recently coauthored a report based on the …

Continue reading »

Jan 26

Ischemic stroke may be added to the list of health risks already associated with the recreational street drug spice

Ischemic stroke may be added to the list of health risks already associated with the recreational street drug spice, a team of neurologists from the University of South Florida (USF), in Tampa, suggests. In a new report published in the December 10 issue of Neurology, the authors discuss the cases of 2 young and previously …

Continue reading »

Jan 25

Findings from a new post hoc analysis of the Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation (COURAGE)

Findings from a new post hoc analysis of the Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation (COURAGE) trial led by Dr GB John Mancini(University of British Columbia, Vancouver suggest that coronary anatomy, and not ischemic disease burden, significantly predicts the risk of death, MI, and non–ST–elevation acute coronary syndrome (NSTE–ACS) in patients with stable …

Continue reading »

Jan 24

Patients were classified as high, intermediate, or low risk for cardiovascular disease.

A screening approach that selectively uses laboratory-based cholesterol testing to assess cardiovascular risk is able to identify patients at risk for cardiovascular disease to a similar extent as a widely used risk model. The multistage primary cardiovascular disease screening approach, in which only patients first identified as at intermediate risk of cardiovascular events are sent …

Continue reading »

Jan 24

A Mediterranean diet may not only reduce the risk of stroke and MI in high-risk patients

A Mediterranean diet may not only reduce the risk of stroke and MI in high-risk patients, but for the first time, a randomized trial suggests that this diet may be linked with a lower risk of peripheral artery disease (PAD). In close to five years of follow-up, compared with high–risk patients who followed a low–fat …

Continue reading »

Older posts «